Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving Idursulfase

NCT00630747 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Hunter Syndrome
Mucopolysaccharidosis II (MPS II)

Interventions

BIOLOGICAL: Idursulfase

Sponsor

Shire